Persons with dispensed medicines; background and generation

Persons with dispensed medicines; background and generation

Sex Age Background and generation Medicine group (ATC) Periods Persons with medicines, relative (%)
Total male and female Total age Total background and generation C05C Capillary stabilizing agents 2020* 0.00
Total male and female Total age Total background and generation G02B Contraceptives for topical use 2020* 0.09
Total male and female Total age Total background and generation G03A Hormonal contraceptives system. use 2020* 1.94
Total male and female Total age Dutch background C05C Capillary stabilizing agents 2020* 0.00
Total male and female Total age Dutch background G02B Contraceptives for topical use 2020* 0.10
Total male and female Total age Dutch background G03A Hormonal contraceptives system. use 2020* 2.22
Total male and female Total age With migration background C05C Capillary stabilizing agents 2020* 0.00
Total male and female Total age With migration background G02B Contraceptives for topical use 2020* 0.05
Total male and female Total age With migration background G03A Hormonal contraceptives system. use 2020* 1.11
Total male and female Total age 1st generation migration background C05C Capillary stabilizing agents 2020* 0.00
Total male and female Total age 1st generation migration background G02B Contraceptives for topical use 2020* 0.02
Total male and female Total age 1st generation migration background G03A Hormonal contraceptives system. use 2020* 0.37
Total male and female Total age 2nd generation migration background C05C Capillary stabilizing agents 2020* 0.00
Total male and female Total age 2nd generation migration background G02B Contraceptives for topical use 2020* 0.08
Total male and female Total age 2nd generation migration background G03A Hormonal contraceptives system. use 2020* 2.01
Total male and female Total age Western migration background C05C Capillary stabilizing agents 2020* 0.00
Total male and female Total age Western migration background G02B Contraceptives for topical use 2020* 0.06
Total male and female Total age Western migration background G03A Hormonal contraceptives system. use 2020* 1.07
Total male and female Total age Non-western migration background C05C Capillary stabilizing agents 2020* 0.00
Total male and female Total age Non-western migration background G02B Contraceptives for topical use 2020* 0.04
Total male and female Total age Non-western migration background G03A Hormonal contraceptives system. use 2020* 1.14
Total male and female Total age Morocco C05C Capillary stabilizing agents 2020* 0.00
Total male and female Total age Morocco G02B Contraceptives for topical use 2020* 0.02
Total male and female Total age Morocco G03A Hormonal contraceptives system. use 2020* 0.66
Total male and female Total age Turkey C05C Capillary stabilizing agents 2020* 0.00
Total male and female Total age Turkey G02B Contraceptives for topical use 2020* 0.01
Total male and female Total age Turkey G03A Hormonal contraceptives system. use 2020* 0.72
Total male and female Total age Surinam C05C Capillary stabilizing agents 2020* 0.00
Total male and female Total age Surinam G02B Contraceptives for topical use 2020* 0.06
Total male and female Total age Surinam G03A Hormonal contraceptives system. use 2020* 1.75
Total male and female Total age (former) Net Antilles, Aruba C05C Capillary stabilizing agents 2020* 0.00
Total male and female Total age (former) Net Antilles, Aruba G02B Contraceptives for topical use 2020* 0.10
Total male and female Total age (former) Net Antilles, Aruba G03A Hormonal contraceptives system. use 2020* 2.09
Total male and female Total age Other non-western background C05C Capillary stabilizing agents 2020* 0.00
Total male and female Total age Other non-western background G02B Contraceptives for topical use 2020* 0.05
Total male and female Total age Other non-western background G03A Hormonal contraceptives system. use 2020* 1.13
Total male and female 0 to 14 years Total background and generation C05C Capillary stabilizing agents 2020* 0.00
Total male and female 0 to 14 years Total background and generation G02B Contraceptives for topical use 2020* 0.00
Total male and female 0 to 14 years Total background and generation G03A Hormonal contraceptives system. use 2020* 0.50
Total male and female 0 to 14 years Dutch background C05C Capillary stabilizing agents 2020* 0.00
Total male and female 0 to 14 years Dutch background G02B Contraceptives for topical use 2020* 0.00
Total male and female 0 to 14 years Dutch background G03A Hormonal contraceptives system. use 2020* 0.61
Total male and female 0 to 14 years With migration background C05C Capillary stabilizing agents 2020* 0.00
Total male and female 0 to 14 years With migration background G02B Contraceptives for topical use 2020* 0.00
Total male and female 0 to 14 years With migration background G03A Hormonal contraceptives system. use 2020* 0.22
Total male and female 0 to 14 years 1st generation migration background C05C Capillary stabilizing agents 2020* 0.00
Total male and female 0 to 14 years 1st generation migration background G02B Contraceptives for topical use 2020* 0.00
Total male and female 0 to 14 years 1st generation migration background G03A Hormonal contraceptives system. use 2020* 0.18
Total male and female 0 to 14 years 2nd generation migration background C05C Capillary stabilizing agents 2020* 0.00
Total male and female 0 to 14 years 2nd generation migration background G02B Contraceptives for topical use 2020* 0.00
Total male and female 0 to 14 years 2nd generation migration background G03A Hormonal contraceptives system. use 2020* 0.23
Total male and female 0 to 14 years Western migration background C05C Capillary stabilizing agents 2020* 0.00
Total male and female 0 to 14 years Western migration background G02B Contraceptives for topical use 2020* 0.00
Total male and female 0 to 14 years Western migration background G03A Hormonal contraceptives system. use 2020* 0.27
Total male and female 0 to 14 years Non-western migration background C05C Capillary stabilizing agents 2020* 0.00
Total male and female 0 to 14 years Non-western migration background G02B Contraceptives for topical use 2020* 0.00
Total male and female 0 to 14 years Non-western migration background G03A Hormonal contraceptives system. use 2020* 0.20
Total male and female 0 to 14 years Morocco C05C Capillary stabilizing agents 2020* 0.00
Total male and female 0 to 14 years Morocco G02B Contraceptives for topical use 2020* 0.00
Total male and female 0 to 14 years Morocco G03A Hormonal contraceptives system. use 2020* 0.10
Total male and female 0 to 14 years Turkey C05C Capillary stabilizing agents 2020* 0.00
Total male and female 0 to 14 years Turkey G02B Contraceptives for topical use 2020* 0.00
Total male and female 0 to 14 years Turkey G03A Hormonal contraceptives system. use 2020* 0.15
Total male and female 0 to 14 years Surinam C05C Capillary stabilizing agents 2020* 0.00
Total male and female 0 to 14 years Surinam G02B Contraceptives for topical use 2020* 0.00
Total male and female 0 to 14 years Surinam G03A Hormonal contraceptives system. use 2020* 0.49
Total male and female 0 to 14 years (former) Net Antilles, Aruba C05C Capillary stabilizing agents 2020* 0.00
Total male and female 0 to 14 years (former) Net Antilles, Aruba G02B Contraceptives for topical use 2020* 0.00
Total male and female 0 to 14 years (former) Net Antilles, Aruba G03A Hormonal contraceptives system. use 2020* 0.38
Total male and female 0 to 14 years Other non-western background C05C Capillary stabilizing agents 2020* 0.00
Total male and female 0 to 14 years Other non-western background G02B Contraceptives for topical use 2020* 0.00
Total male and female 0 to 14 years Other non-western background G03A Hormonal contraceptives system. use 2020* 0.17
Total male and female 15 to 24 years Total background and generation C05C Capillary stabilizing agents 2020* 0.00
Total male and female 15 to 24 years Total background and generation G02B Contraceptives for topical use 2020* 0.71
Total male and female 15 to 24 years Total background and generation G03A Hormonal contraceptives system. use 2020* 15.24
Total male and female 15 to 24 years Dutch background C05C Capillary stabilizing agents 2020* 0.00
Total male and female 15 to 24 years Dutch background G02B Contraceptives for topical use 2020* 0.87
Total male and female 15 to 24 years Dutch background G03A Hormonal contraceptives system. use 2020* 18.55
Total male and female 15 to 24 years With migration background C05C Capillary stabilizing agents 2020* 0.00
Total male and female 15 to 24 years With migration background G02B Contraceptives for topical use 2020* 0.34
Total male and female 15 to 24 years With migration background G03A Hormonal contraceptives system. use 2020* 7.39
Total male and female 15 to 24 years 1st generation migration background C05C Capillary stabilizing agents 2020* 0.00
Total male and female 15 to 24 years 1st generation migration background G02B Contraceptives for topical use 2020* 0.18
Total male and female 15 to 24 years 1st generation migration background G03A Hormonal contraceptives system. use 2020* 3.36
Total male and female 15 to 24 years 2nd generation migration background C05C Capillary stabilizing agents 2020* 0.00
Total male and female 15 to 24 years 2nd generation migration background G02B Contraceptives for topical use 2020* 0.44
Total male and female 15 to 24 years 2nd generation migration background G03A Hormonal contraceptives system. use 2020* 10.09
Total male and female 15 to 24 years Western migration background C05C Capillary stabilizing agents 2020* 0.00
Total male and female 15 to 24 years Western migration background G02B Contraceptives for topical use 2020* 0.45
Total male and female 15 to 24 years Western migration background G03A Hormonal contraceptives system. use 2020* 8.47
Total male and female 15 to 24 years Non-western migration background C05C Capillary stabilizing agents 2020* 0.00
Total male and female 15 to 24 years Non-western migration background G02B Contraceptives for topical use 2020* 0.27
Total male and female 15 to 24 years Non-western migration background G03A Hormonal contraceptives system. use 2020* 6.75
Total male and female 15 to 24 years Morocco C05C Capillary stabilizing agents 2020* 0.00
Total male and female 15 to 24 years Morocco G02B Contraceptives for topical use 2020* 0.09
Total male and female 15 to 24 years Morocco G03A Hormonal contraceptives system. use 2020* 3.61
Total male and female 15 to 24 years Turkey C05C Capillary stabilizing agents 2020* 0.00
Total male and female 15 to 24 years Turkey G02B Contraceptives for topical use 2020* 0.09
Total male and female 15 to 24 years Turkey G03A Hormonal contraceptives system. use 2020* 4.30
Total male and female 15 to 24 years Surinam C05C Capillary stabilizing agents 2020* 0.00
Source: CBS.
Explanation of symbols

Table description


This table contains figures on the absolute number of persons to whom in the year concerned medicines were dispensed for which the costs are reimbursed under the statutory basic medical insurance. The figures are also expressed as a percentage of the total population in the category concerned. The population includes everybody registered in the Basic Registration of Persons (BRP) and living in the Netherlands at some point in the year concerned. Until 2010 the figures also included medicines dispensed to persons registered in the BRP, but no longer resident in the Netherlands.
Medicines provided to persons in hospitals and nursing homes are not included; medicines provided in residential homes for the elderly are included.

Data are broken down by medicine group, background, generation, age and sex.

Data available from: 2006

Status of the figures:
Figures for 2020 are provisional. Remaining figures are definite.

Changes as of 10 December, 2021:
Figures for 2019 have been made final and provisional figures for 2020 have been added.

When will new figures be published?
New figures will be published in the last quarter of 2022.

Description topics

Persons with medicines, relative
Number of persons to whom medicines are dispensed in the year concerned that are reimbursed under the statutory basic medical insurance, expressed as a percentage of the total population of the category concerned registered in the Basic Registration of Persons (BRP) in that year.